Annotated Medicine and Device Lists

Omeprazole

Capsule 20 mg Injection 40 mg/mL Injection 40 mg (sodium salt) Injection 40 mg in 10-mL vial Powder for injection 40 mg in vial Powder for oral liquid 20 mg sachets Powder for oral liquid 40 mg sachets Solid oral dosage form 10 mg Solid oral dosage form 20 mg Solid oral dosage form 40 mg Tablet 20-40 mg

This medicine is present in:

List	Section	Observation
Cuba	17.1.3 Inhibidores de la bomba de protones	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Peru	17.1.2 Anti-Ulcers	No observations

This medicine is present in:

List	Section	Observation
Cuba	17.1.3 Inhibidores de la bomba de protones	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (A02BC Proton pump inhibitors) excluding combinations.
PAHO Strategic Fund Medicine List	15.1. Antiulcer	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (A02BC Proton pump inhibitors) excluding combinations.
PAHO Strategic Fund Medicine List	15.1. Antiulcer	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (A02BC Proton pump inhibitors) excluding combinations.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (A02BC Proton pump inhibitors) excluding combinations.
Bolivia	LINAME 2011 - 2013	No observations
Peru	17.1.2 Anti-Ulcers	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	06.5 Peptic Ulcers	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	17.1. Antiulcer medicines	Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (A02BC Proton pump inhibitors) excluding combinations.

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

Information Resources: Omeprazole

Should adults with gastro-esophageal reflux be treated with H2-antagonists compared to proton pump inhibitors?
Gastro-esophageal reflux disease.